Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2023 - Volume 27, Number 1
View All Articles in Issue

Page(s): 52

Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus Page 1

Download in electronic PDF format for $65

Abstract: A formulation for preparing Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, dapsone, formulations, oral suspensions, leprosy, pneumocystis pneumonia, malaria, dermatoses

Related Categories: DERMATOLOGY, EXCIPIENTS, FORMULATIONS, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 415
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 52
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 491
Dapsone 2-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 300
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D	May/Jun 2003 Pg. 233-239
Suspension Solution, Sugar Free Allen Loyd V Jr	Jan/Feb 2023 Pg. 58-59
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Schotik Debora	Jan/Feb 2001 Pg. 9-12
Sorafenib 20-mg/mL in Oil Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 420
Atomoxetine 4-mg/mL Oral Solution/Suspension Allen Loyd V Jr	Jul/Aug 2021 Pg. 321